España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Gilead Sciences
GILD
NASDAQ
Watchlist
Get Report
Perks
Buy
Compare Brokers
$66.69
0.1
0.15%
At Close: -
$66.45
-0.24
-0.36%
After Hours: 7:43 PM EDT
15 minutes delayed
Get Report
Watch
Gilead Sciences (GILD) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Government Trades
Short Interest
Latest news for Gilead Sciences (NASDAQ:GILD) Stock
Gilead Sciences Stock (NASDAQ: GILD)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Monday, July 01, 2024
Key Takeaways From Gilead Sciences Analyst Ratings
Benzinga Insights
RBC Capital Reiterates Sector Perform on Gile...
Benzinga Newsdesk
Friday, June 28, 2024
Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks With Over 3% Dividend Yields
Avi Kapoor
Wednesday, June 26, 2024
Gilead Sciences Canada Announces Phase 3 PURP...
Benzinga Newsdesk
Tuesday, June 25, 2024
10 Health Care Stocks Whale Activity In Today's Session
Benzinga Insights
CNBC Halftime Report Final Trades: Keurig Dr ...
Benzinga Newsdesk
Monday, June 24, 2024
Gilead Sciences's Options Frenzy: What You Need to Know
Benzinga Insights
Sunday, June 23, 2024
DraftKings And Dell Were Among The 10 Biggest Large Cap Stock Gainers Last Week (June 16-June 22): Are These In Your Portfolio?
Lekha Gupta
Friday, June 21, 2024
Nvidia Snaps 8-Week Winning Run, S&P 500 Marks Longest Streak Without A 2% Drop Since Great Recession, Oil Prices Stage Comeback: This Week In The Market
Piero Cingari
Gilead Up as Twice-Yearly HIV Shot Prevents Infection
Zacks
Gilead Sciences Faces Wall Street Speculation About Obesity Drugs Despite Focus On Liver Treatments
Vandana Singh
Why Gilead Sciences Stock Is Trading Higher Friday
Dylan Berman
Gilead Sciences shares are trading higher on ...
Benzinga Newsdesk
Thursday, June 20, 2024
Benzinga Market Summary: Housing Starts Come ...
Benzinga Newsdesk
S&P 500, Nasdaq 100 Dip From Record Highs As Investors Take Chipmaker Profits; Energy Sector Rebounds, Yields Rise: What's Driving Markets Thursday?
Piero Cingari
Baird Maintains Neutral on Gilead Sciences, M...
Benzinga Newsdesk
Why Is Gilead Sciences Stock Trading Higher On Thursday?
Vandana Singh
Benzinga Market Summary: AMD Rises, Jobless C...
Benzinga Newsdesk
KB Home Reports Upbeat Earnings, Joins Harrow, Accenture, Gilead Sciences And Other Big Stocks Moving Higher On Thursday
Avi Kapoor
Gilead shares are trading higher after the co...
Benzinga Newsdesk
Gilead shares are trading higher after the co...
Benzinga Newsdesk
Gilead Announces Results From Interim Analysi...
Benzinga Newsdesk
Wednesday, June 19, 2024
$100 Invested In This Stock 20 Years Ago Would Be Worth $800 Today
Benzinga Insights
Monday, June 17, 2024
Detailed Data From Gilead Halted Blood Cancer Drug Magrolimab Program Shows Higher Deaths And Side Effects
Vandana Singh
Friday, June 14, 2024
What 8 Analyst Ratings Have To Say About Gilead Sciences
Benzinga Insights
RBC Capital Reiterates Sector Perform on Gile...
Benzinga Newsdesk
Gilead's Kite Revealed New Data On Yescarta A...
Benzinga Newsdesk
Thursday, June 13, 2024
10 Health Care Stocks Whale Activity In Today's Session
Benzinga Insights
Wednesday, June 12, 2024
Gilead Exec Says Co Will Will Continue To Loo...
Benzinga Newsdesk
Monday, June 10, 2024
Arcus Biosciences In Collaboration With Gilea...
Benzinga Newsdesk
Friday, June 07, 2024
10 Health Care Stocks With Whale Alerts In Today's Session
Benzinga Insights
Thursday, June 06, 2024
Gilead Sciences' Phase 2B MYR204 Open-label S...
Benzinga Newsdesk
Wednesday, June 05, 2024
$100 Invested In This Stock 20 Years Ago Would Be Worth $800 Today
Benzinga Insights
Gilead's Seladelpar Shows Continued And Relia...
Benzinga Newsdesk
Tuesday, June 04, 2024
National Institutes of Health Kickstarts Gilead Sponsored Trials For Twice-Yearly HIV Prevention Injection
Vandana Singh
Gilead Sciences Reaches Agreement In Principl...
Benzinga Newsdesk
Monday, June 03, 2024
After Disappointing Bladder Cancer Data, Gilead Announces Encouraging Data From Gastric, Colorectal Cancer Studies
Vandana Singh
Kite's Tecartus Shows 40% Four-Year Overall S...
Benzinga Newsdesk
Kite, A Gilead Company Presents New Data On Y...
Benzinga Newsdesk
Sunday, June 02, 2024
Gilead And Arcus Announced Etrumadenant Plus Zimberelimab, FOLFOX, And Bevacizumab Reduce Death Risk By 63% And Disease Progression by 73% vs Regorafenib In Phase 1b/2 Trial For Third-Line Metastatic Colorectal Cancer
Charles Gross
Friday, May 31, 2024
Gilead shares are trading lower after the com...
Benzinga Newsdesk
Gilead's Trodelvy Fails To Hit Primary Goal In Late-Stage Study With Most Common Type Of Bladder Cancer
Vandana Singh
Gilead Sciences To Present EVOKE-01 Study Res...
Benzinga Newsdesk
Thursday, May 30, 2024
Gilead shares are trading lower after the com...
Benzinga Newsdesk
Gilead Sciences Announces Topline Results Fro...
Benzinga Newsdesk
Tuesday, May 21, 2024
$100 Invested In This Stock 20 Years Ago Would Be Worth $800 Today
Benzinga Insights
Monday, May 20, 2024
Gilead's Recently Acquired Liver Disease Candidate Shows Improvements In Disease Progression And Associated Itch
Vandana Singh
Reported Saturday, Gilead Sciences Announced ...
Benzinga Newsdesk
Wednesday, May 15, 2024
Market Whales and Their Recent Bets on GILD Options
Benzinga Insights
Friday, May 10, 2024
Decoding Gilead Sciences's Options Activity: What's the Big Picture?
Benzinga Insights
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch